Literature DB >> 34629719

Biliary-Caval Fistula following Y90 Radioembolization.

Alexander D Hall1, Sarah B White1, William S Rilling1.   

Abstract

The safety of radioembolization with yttrium-90 ( 90 Y) is well documented and major complications are rare. Previous studies have demonstrated that biliary complications following 90 Y, including bile duct injury and hepatic abscess formation, occur at an increased rate in patients who have had prior biliary surgery and interventions. This article reviews a case of a patient who developed recurrent cholangitis and sepsis as well as a biliary-caval fistula following radioembolization. Additionally, we review current data regarding biliary complications following radioembolization in patients with prior biliary intervention. Thieme. All rights reserved.

Entities:  

Keywords:  90 Y ; biliary infection; cholangitis; interventional radiology; liver-directed therapy; radioembolization

Year:  2021        PMID: 34629719      PMCID: PMC8497092          DOI: 10.1055/s-0041-1735605

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.780


  25 in total

Review 1.  Current status of transarterial radioembolization.

Authors:  Andreas H Mahnken
Journal:  World J Radiol       Date:  2016-05-28

2.  Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.

Authors:  B Gray; G Van Hazel; M Hope; M Burton; P Moroz; J Anderson; V Gebski
Journal:  Ann Oncol       Date:  2001-12       Impact factor: 32.976

3.  Infection Rates Following Hepatic Embolotherapy in Patients with Prior Biliary Interventions: Comparison of Single-Drug Moxifloxacin and Multidrug Antibiotic Prophylaxis.

Authors:  Rupal S Parikh; Omar Abousoud; Stephen Hunt; Terence Gade; Mandeep Dagli; Jeffrey Mondschein; Susan Shamimi-Noori; Deepak Sudheendra; S William Stavropoulos; Michael C Soulen; Gregory J Nadolski
Journal:  J Vasc Interv Radiol       Date:  2021-02-27       Impact factor: 3.464

4.  Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.

Authors:  Ravi Murthy; Henry Xiong; Rodolfo Nunez; Alan C Cohen; Bruce Barron; Janio Szklaruk; David C Madoff; Sanjay Gupta; Michael J Wallace; Kamran Ahrar; Marshall E Hicks
Journal:  J Vasc Interv Radiol       Date:  2005-07       Impact factor: 3.464

5.  Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors.

Authors:  Jean-Francois H Geschwind; Shaifali Kaushik; Douglas E Ramsey; Michael A Choti; Elliot K Fishman; Hicham Kobeiter
Journal:  J Vasc Interv Radiol       Date:  2002-11       Impact factor: 3.464

6.  Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy.

Authors:  Jeong-Sik Yu; Ki Whang Kim; Mi-Gyoung Jeong; Deok Hee Lee; Mi-Suk Park; Sang-Wook Yoon
Journal:  Cardiovasc Intervent Radiol       Date:  2002-06-04       Impact factor: 2.740

7.  Hepatic radioembolization complicated by abscess.

Authors:  Neil Mascarenhas; Robert K Ryu; Riad Salem
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

8.  Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome.

Authors:  S Y Song; J W Chung; J K Han; H G Lim; Y H Koh; J H Park; H S Lee; C Y Kim
Journal:  J Vasc Interv Radiol       Date:  2001-03       Impact factor: 3.464

9.  Biliary sequelae following radioembolization with Yttrium-90 microspheres.

Authors:  Bassel Atassi; Affaan K Bangash; Robert J Lewandowski; Saad Ibrahim; Laura Kulik; Mary F Mulcahy; Ravi Murthy; Robert K Ryu; Kent T Sato; Frank H Miller; Reed A Omary; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2008-03-17       Impact factor: 3.464

10.  Hepatic abscess after yttrium-90 radioembolization for islet-cell tumor hepatic metastasis.

Authors:  Neil B Mascarenhas; Mary F Mulcahy; Robert J Lewandowski; Riad Salem; Robert K Ryu
Journal:  Cardiovasc Intervent Radiol       Date:  2009-08-18       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.